(MedPage Today)-The agency announced on Friday-The Food and Drug Administration (FDA) announced the first diagnostic test in the laboratory for Alzheimer’s disease. A blood test, known as Lumipulse G Ptau 217/β-β-β-β-β-β-β-β-β-amyloid 1-42, can be used to detect amyloid …
